Novo Nordisk A/S ADR (NVO) Stock Price, Quote & News

Company Profile

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The c...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 45 44 44 88 88

Website: www.novonordisk.com

Address:

Novo Alle 1, Bagsvaerd, Denmark

twincam Sep. 23 at 1:35 AM

$VKTX I am but a bull on $VKTX. 🐂 Big Pharma has dry powder + looming patent cliffs. Strategic names to watch: $MRK, $AZN, $NVO. No confirmed M&A. Biotech carries significant clinical, regulatory, competitive & valuation risk. This is speculation, not financial advice. DYODD.

0 · Reply

Rolex53 Sep. 23 at 1:34 AM

$VKTX I can sell for $200 per share if $NVO wish to buy us.

0 · Reply

Baazigar123 Sep. 23 at 1:01 AM

$NVO no hope in US market

0 · Reply

cmentor11 Sep. 23 at 12:53 AM

$HIMS $NVO Wrong…$60 by EOY.

0 · Reply

mikesterz7 Sep. 23 at 12:39 AM

$NVO $HIMS 🔥🔥🔥 Dips

0 · Reply

kevie6537 Sep. 22 at 11:44 PM

$NVO only thing that saves bulls tomorrow is news Otherwise more bleeding

0 · Reply

Staszek Sep. 22 at 11:04 PM

$NVO The foundation holds a majority stake, so they don't need to buy shares—that’s what the buyback is for. It’s carried out by a bank on Novo’s behalf, involving around 220,000 shares daily on the Danish market. Neither the foundation nor the management is overly concerned with the share price, since a takeover isn't possible; consequently, they face no pressure to inflate the valuation or appease Wall Street. From their perspective, a low price is actually great because it means they can buy shares more cheaply...

1 · Reply

fiiked Sep. 22 at 11:00 PM

$NVO how much more man.. they dumped it so bad it has been down since forever.. even hims goes up sometimes this is down from 70 to 36 in a year. I guess downfall is inevitable

0 · Reply

Woodmont Sep. 22 at 10:49 PM

$NVO Remember the foundation owns almost 30% of all stock and we know they are not selling, they should be buying and creating a Volkswagen type moment taking shares off the market, someone on here mentioned that earlier today I don’t think anything like that could happen here unless the foundation aquired a massive amount of outstanding shares and we had a life changing moment of amazing news on some new type drug but we can all dream

1 · Reply

Moca63 Sep. 22 at 10:18 PM

$NVO , The lion share of NVO pipeline is weight loss/diabetes. Did they take too long to pivot to other products knowing the patent expiration coming and rapidly growing competition?

0 · Reply

Novo Nordisk Has a Fresh New Name -- but It Still Faces the Same Old Problems

2026-09-22T16:37:09.000Z - 9 hours ago

Novo Nordisk Just Made a Surprising Move Beyond Weight Loss

2026-09-22T15:56:17.000Z - 9 hours ago

Novo Nordisk price target lowered to DKK 245 from DKK 265 at Deutsche Bank

Tue, 22 Sep 2026 11:16:11 -0400 - 10 hours ago

Novo CEO says pills could capture 50% of weight-loss market by 2030

2026-09-22T15:04:10.000Z - 10 hours ago

European drugmakers say they are ‘losing ground’ to US and Chinese rivals

Tue, 22 Sep 2026 09:42:53 -0400 - 12 hours ago

European drugmakers call for faster trials, more spending to compete with US, China

Tue, 22 Sep 2026 08:22:00 -0400 - 13 hours ago

Viking Therapeutics Stock Surges 36%. It Could Challenge Lilly and Novo's Obesity Empire.

Tue, 22 Sep 2026 08:01:41 -0400 - 13 hours ago

Novo Nordisk and UNICEF renew push to prevent childhood obesity

Tue, 22 Sep 2026 07:34:54 -0400 - 14 hours ago

Novo's CEO Called Ozempic's Patent Cliff the "Elephant in the Room" Yesterday. Is the Stock Still a Buy?

2026-09-22T10:20:47.000Z - 15 hours ago

Novo CEO says company needs to increase investor confidence, Bloomberg says

Tue, 22 Sep 2026 06:18:22 -0400 - 15 hours ago

Novo CEO on M&A: Let's see where the gaps are

2026-09-22T09:43:03.000Z - 16 hours ago

Novo Stock (NVO): Deutsche Bank Keeps Sell Rating, Says Growth Strategy ‘Underwhelming on Multiple Fronts’

LLY

Tue, 22 Sep 2026 05:00:49 -0400 - 16 hours ago

Novo CEO signals M&A opportunities to strengthen drug pipeline

Tue, 22 Sep 2026 03:12:42 -0400 - 18 hours ago

Novo Still Has Work to Do to Build Investor Confidence, CEO Says

2026-09-21T22:16:14.000Z - 1 day ago

Is Novo Nordisk AS (NVO) a Bargain After 8.0% Drop? GF Value Says Undervalued

2026-09-21T21:50:50.000Z - 1 day ago

Novo Nordisk is a value trap, says UBS' Michael Yee

Mon, 21 Sep 2026 17:00:13 -0400 - 1 day ago

Monday's Final Takeaways: NVO Stumbles in GLP-1 Race, U.S.-China Summit Begins

Mon, 21 Sep 2026 15:02:36 -0400 - 1 day ago

Novo Nordisk Targets Five Multi-Blockbusters by 2030 as Oral Wegovy Gains Traction

2026-09-21T17:14:11.000Z - 1 day ago

Novo Nordisk Faces Challenges Amid Capital Markets Day Insights

Mon, 21 Sep 2026 11:54:29 -0400 - 1 day ago

Why Novo Nordisk Stock Just Crashed

2026-09-21T14:10:40.000Z - 1 day ago

Novo Nordisk (NVO) Cuts Jobs Amid Competitive Pressure and Plans New Drug Launches

2026-09-21T14:05:46.000Z - 1 day ago

Novo Nordisk falls -7.1%

2026-09-21T14:02:15.000Z - 1 day ago

Eli Lilly Stock (LLY) Rises as Novo’s Growth Strategy Fails to Impress Wall Street

LLY

2026-09-21T13:52:36.000Z - 1 day ago

Novo Stock (NVO) Drops 5% Despite Beating Eli Lilly in New CagriSema Trial After Earlier Failure

LLY

2026-09-21T13:00:44.297Z - 1 day ago

Wegovy-maker Novo shares slump as management grilled on pricing, M&A

2026-09-21T12:36:12.000Z - 1 day ago

First Look: US Futures Rise, Bitcoin Hits $85K, Novo Nordisk Drops

2026-09-21T12:35:03.000Z - 1 day ago

Novo Nordisk's $23B Obesity Goal Isn't Enough to Stop the Selloff

Mon, 21 Sep 2026 08:29:00 -0400 - 1 day ago

Why Novo Stock Is Dropping After Drugmaker Unveils Ambitious Growth Plan

2026-09-21T12:20:29.000Z - 1 day ago

Novo Nordisk Stock Drops 5.6% as 2030 Goals Match Peers

Mon, 21 Sep 2026 06:46:57 -0400 - 1 day ago

Novo says its next-gen obesity drug tops Lilly rival in late-stage study

2026-09-21T10:40:02.000Z - 1 day ago

Novo Stock (NVO) Is Falling in Pre-Market Today, September 21 — Here’s Why

LLY

2026-09-21T10:30:29.000Z - 1 day ago

Novo Nordisk (NVO) Faces Stock Drop Amid New Growth Targets Announcement

2026-09-21T10:21:41.000Z - 1 day ago

Novo Nordisk Shares Sink After $23 Billion Obesity Sales Target for 2030

2026-09-21T10:12:36.000Z - 1 day ago

Novo Nordisk Sets Ambitious Growth Targets Amid Competitive Obesity Drug Market

Mon, 21 Sep 2026 05:50:53 -0400 - 1 day ago

Novo Nordisk aims to launch more than five blockbuster drugs by 2030, CEO says

Mon, 21 Sep 2026 05:46:45 -0400 - 1 day ago

Novo stock falls 6%: new blockbuster drugs plan, $23B sales target fails to impress

2026-09-21T09:40:25.000Z - 1 day ago

Novo Nordisk sees 2035 pipeline sales over DKK 150B

Mon, 21 Sep 2026 05:15:00 -0400 - 1 day ago

Wegovy Maker Novo Nordisk Targets Several New Blockbuster Drugs in Coming Years

Mon, 21 Sep 2026 05:14:00 -0400 - 1 day ago

Wegovy Maker Novo Nordisk Targets Several New Blockbuster Drugs in Coming Years — Update

Mon, 21 Sep 2026 04:58:00 -0400 - 1 day ago

Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals

Mon, 21 Sep 2026 04:36:07 -0400 - 1 day ago

Novo shares sink as weight-loss drug giant unveils 2030 strategy

Mon, 21 Sep 2026 04:31:28 -0400 - 1 day ago

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

Sep 21, 2026, 4:00 AM EDT - 1 day ago

Novo Nordisk Transcript: CMD 2026

Sep 21, 2026, 4:00 AM EDT - 1 day ago

Novo Nordisk Press release: FY 2026

Sep 21, 2026, 4:00 AM EDT - 1 day ago

Novo Nordisk Slides: FY 2026

2026-09-21T07:00:00.000Z - 1 day ago

Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drug

Mon, 21 Sep 2026 01:02:59 -0400 - 1 day ago

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs

2026-09-20T14:55:10.000Z - 2 days ago

Eli Lilly, Novo sued over risk of sudden vision loss, WSJ reports

LLY

2026-09-20T06:50:27.000Z - 2 days ago

Novo Nordisk Needs to Diversify Beyond Ozempic, Say Shareholders

Fri, 18 Sep 2026 20:00:00 -0400 - 4 days ago

Patients are suing GLP-1 drugmakers over the risk of sudden vision loss. The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the U.S.

Fri, 18 Sep 2026 12:30:11 -0400 - 4 days ago

40% of U.S. Adults to Use GLP-1s? Raul Shah on LLY, NVO & Weight Loss "Mania"

2026-09-18T12:12:53.000Z - 4 days ago

Novo's Sogroya Gets Positive EU Opinion For Children With Idiopathic Short Stature

2026-09-18T07:16:45.000Z - 4 days ago

Orbis Medicines Partners With Novo In Up To $1.4 Billion Drug Discovery Deal

2026-09-17T14:30:37.000Z - 5 days ago

Novo Nordisk reports CHMP adopts positive opinion on MAA for Frehemgo

2026-09-17T11:20:13.000Z - 5 days ago

Novo Nordisk announces FRONTIER5 Phase 3b results for denecimig

Sep 17, 2026, 7:03 AM EDT - 5 days ago

Novo, Orbis sign up to $1.4 billion deal to develop oral drugs

Sep 17, 2026, 7:00 AM EDT - 5 days ago

Orbis Medicines Enters Multi-Target Drug Discovery Partnership with Novo Nordisk Worth up to USD 1.4 Billion

Sep 16, 2026, 12:33 PM EDT - 6 days ago

Will AI Save the Pharma Industry Billions? Novo's Anthropic Deal Is Betting on It.

Sep 16, 2026, 9:15 AM EDT - 6 days ago

Novo partners with Anthropic to speed up drug development with Claude

Sep 16, 2026, 8:32 AM EDT - 6 days ago

Novo Partners With Anthropic to Speed Up Drug Discovery Using Claude

Sep 15, 2026, 10:33 AM EDT - 7 days ago

Novo CEO urges staff to embrace more customer-focused culture

Sep 14, 2026, 3:09 PM EDT - 8 days ago

Novo CEO talks about rebrand, corporate changes amid fight for obesity market share

Sep 14, 2026, 9:59 AM EDT - 8 days ago

Novo Nordisk rebrands as 'Novo', announces cultural reset

Sep 14, 2026, 9:20 AM EDT - 8 days ago

Novo drops ‘Nordisk' in corporate refresh to take on Lilly in the weight-loss wars

Sep 14, 2026, 4:56 AM EDT - 8 days ago

Novo Nordisk to Rebrand as Novo

Sep 14, 2026, 3:00 AM EDT - 8 days ago

Novo Nordisk rebrands to 'Novo,' unveils corporate changes as it fights for obesity market share

Sep 12, 2026, 5:30 AM EDT - 10 days ago

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness

AMGN NVS

Sep 11, 2026, 10:30 AM EDT - 11 days ago

Friday's First Moves: RH & KR Earnings Mixed, NVO Downgrade

KR RH

Sep 10, 2026, 4:09 AM EDT - 12 days ago

Novo Nordisk says Wegovy approved in China for liver disease MASH

Sep 7, 2026, 11:00 AM EDT - 15 days ago

Ozempic maker: We sold health when people wanted weight loss

Sep 7, 2026, 7:44 AM EDT - 15 days ago

Novo scraps two more heart drug trials, further dimming growth beyond obesity

Sep 7, 2026, 6:57 AM EDT - 15 days ago

Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial

Sep 7, 2026, 6:47 AM EDT - 15 days ago

Novo Nordisk says semaglutide cut obesity rates in young children in trial

Sep 5, 2026, 8:30 AM EDT - 17 days ago

Plastic surgery is booming with boomers. Here's how to cash in on the antiaging craze.

ABBV AIRS LLY

Sep 1, 2026, 4:55 AM EDT - 21 days ago

Novo Nordisk launches Wegovy weight-loss pill in Germany

Aug 31, 2026, 6:25 PM EDT - 22 days ago

GLP-1 weight loss drugs effective even at low starter doses

LLY

Aug 31, 2026, 3:42 PM EDT - 22 days ago

600,000 seniors have signed up for obesity drugs under new Medicare program

LLY

Aug 31, 2026, 1:20 PM EDT - 22 days ago

Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers

LLY PFE TAK

Aug 27, 2026, 2:39 PM EDT - 26 days ago

Novo Nordisk stock falls as Deutsche Bank downgrades shares to sell

Aug 27, 2026, 11:46 AM EDT - 26 days ago

Novo Nordisk Stock Is Downgraded to Sell, and GLP-1s Aren't the Reason

Aug 27, 2026, 10:18 AM EDT - 26 days ago

Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth Concerns

Aug 27, 2026, 4:37 AM EDT - 26 days ago

Ozempic maker Novo Nordisk downgraded to sell after 70% stock-price dive from peak

Aug 26, 2026, 11:47 PM EDT - 26 days ago

China drug regulator accepts Novo Nordisk's application for oral Wegovy

Aug 20, 2026, 7:00 AM EDT - 4 weeks ago

Celon Pharma's generic semaglutide drug matches Ozempic in early study, shares jump

Aug 19, 2026, 8:33 AM EDT - 4 weeks ago

Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills

twincam Sep. 23 at 1:35 AM

0 · Reply

Rolex53 Sep. 23 at 1:34 AM

$VKTX I can sell for $200 per share if $NVO wish to buy us.

0 · Reply

Baazigar123 Sep. 23 at 1:01 AM

$NVO no hope in US market

0 · Reply

cmentor11 Sep. 23 at 12:53 AM

$HIMS $NVO Wrong…$60 by EOY.

0 · Reply

mikesterz7 Sep. 23 at 12:39 AM

$NVO $HIMS 🔥🔥🔥 Dips

0 · Reply

kevie6537 Sep. 22 at 11:44 PM

$NVO only thing that saves bulls tomorrow is news Otherwise more bleeding

0 · Reply

Staszek Sep. 22 at 11:04 PM

1 · Reply

fiiked Sep. 22 at 11:00 PM

$NVO how much more man.. they dumped it so bad it has been down since forever.. even hims goes up sometimes this is down from 70 to 36 in a year. I guess downfall is inevitable

0 · Reply

Woodmont Sep. 22 at 10:49 PM

1 · Reply

Moca63 Sep. 22 at 10:18 PM

$NVO , The lion share of NVO pipeline is weight loss/diabetes. Did they take too long to pivot to other products knowing the patent expiration coming and rapidly growing competition?

0 · Reply

DoomBot1 Sep. 22 at 10:06 PM

$NVO $LLY $VKTX lol, keep buying novo "cheap" shares bulls, 0 IQ.

0 · Reply

qzz5013 Sep. 22 at 9:58 PM

$NVO it’s pe is under 10 and company is still growing . Don’t get fear mongering and believe in the numbers. I’m holding my shares despite being 10% down. No biggies

1 · Reply

durocali Sep. 22 at 9:41 PM

$VKTX the CNBC talking head table all but stopped short of dialing $NVO up on the phone during the live broadcast to push them on considering a b/o here.

1 · Reply

TechridyStocks Sep. 22 at 9:36 PM

$VKTX basically $NVO has to buy this.

0 · Reply

Moca63 Sep. 22 at 9:32 PM

$NVO , is there any chance NOVO goes private? NVO holdings owns 29% of shares.

0 · Reply

Showyouthemoney Sep. 22 at 9:11 PM

$NVO I hear talking heads on CNBC today saying how they think Lilly will double in a year and getting excited about their GLP oral, but NVO that is absolutely dominating oral gets no mention, none. I think it is starting to get silly….

1 · Reply

BEST_MAN_EVER Sep. 22 at 9:09 PM

$NVO 150 to 39

0 · Reply

THE_ORJINAL Sep. 22 at 8:44 PM

$ALT It can't be understated how big a shift this is for $NVO. Their history of avoiding GCGR is deliberate and deep. Stat News had a great article summarizing why $NVO has avoided glucagon last year. The top GCGR focused biotech is undoubtedly ALT. They have to be in Novo's new crosshairs. https://www.statnews.com/2025/06/05/novo-nordisk-weight-loss-drugs-market-dominance-slips-eli-lilly-gains-here-is-why/

1 · Reply

IndyOne Sep. 22 at 8:26 PM

$NVO This stock is a no touch. Have a small position, already down 10%. Yikes.

0 · Reply

CanadaPride Sep. 22 at 8:23 PM

$NVO we need market to respect NVO's sp . We should be 70-80 range in next 2 to 3 months...and looking to break all time high later part of 2027.

3 · Reply

CanadaPride Sep. 22 at 8:22 PM

$NVO now look at revenue growth.

1 · Reply

CanadaPride Sep. 22 at 8:20 PM

$NVO look at last 6 quarters. TTm revenues stand 50B and mcap is 176B. Net profit..yes net profit almoat 18B annual

0 · Reply

Market Cap	193.07B
Revenue (ttm)	46.79B
Net Income (ttm)	15.51B
EPS (ttm)	N/A
PE Ratio	10.76
Forward PE	12.25
Profit Margin	33.14%
Debt to Equity Ratio	0.63

Volume	24,462,800
Avg Vol	12,128,934
Day's Range	N/A - N/A
Shares Out	4.47B
Stochastic %K	4%
Beta	0.74
Analysts	Hold
Price Target	$46.42